Peritoneal dialysis effluent as a non-potable water resource: Biochemical and microbiological characterization compared to treated wastewater

Welcome to AudioScholar. Today we're covering "Peritoneal dialysis effluent as a non-potable water resource: Biochemical and microbiological characterization compared to treated wastewater," by Cruz-Cruz C and colleagues, published in *Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis*.

As healthcare grapples with its environmental footprint, the concept of "green nephrology" has gained traction. Dialysis, in particular, is a resource-intensive therapy. While much attention has been paid to the water consumption of in-center hemodialysis, less has been focused on the waste generated by peritoneal dialysis. In countries like Mexico, where this study was conducted, nearly half of all patients on renal replacement therapy use continuous ambulatory peritoneal dialysis, or CAPD. Each of these patients generates several liters of peritoneal dialysis effluent, or PDE, every single day. This fluid, rich in uremic toxins, is typically just flushed down the toilet. This study asks a fundamental question: could this discarded effluent be a resource? To answer that, the researchers set out to provide the first detailed characterization of what’s actually in this fluid, comparing it to treated municipal wastewater to understand its potential for non-potable reuse, such as in agriculture or industry.

This was a cross-sectional, comparative study conducted in Mexico City. The researchers collected samples of peritoneal dialysis effluent from twenty adult patients with chronic kidney disease who were stable on CAPD and had no evidence of peritonitis. The dialysate used was a standard 1.5% dextrose solution. For comparison, they collected eighteen samples of treated wastewater from various urban and industrial treatment plants. This treated wastewater serves as a real-world benchmark, as it's a fluid source already subject to regulations for non-potable reuse. In the lab, both types of fluid underwent a comprehensive analysis. Biochemically, the team measured key solutes like glucose, urea, creatinine, and electrolytes, as well as pH and residual chlorine. Microbiologically, they used classical culture methods to quantify a range of microbes, including total aerobic bacteria, gram-negative and gram-positive bacteria, coliforms, and fungi. The goal was to create a detailed profile of the effluent to see if it was biochemically or microbiologically safe for potential reuse, and what kind of further treatment it might need.

The results painted a picture of two very different liquids, with findings that were both expected and strikingly clear.

First, let's look at the biochemical profile. As one would predict, the peritoneal dialysis effluent was heavily loaded with solutes removed from the patient's blood. Compared to the treated wastewater, the effluent had significantly higher concentrations of glucose, nitrogenous wastes, and electrolytes. For instance, the mean glucose level in the effluent was over 750 milligrams per deciliter, a direct result of the dextrose-based dialysate. In the treated wastewater, glucose was virtually undetectable. Similarly, urea nitrogen in the effluent was above 100 milligrams per deciliter, and levels of creatinine and uric acid were also substantially elevated compared to the wastewater. Electrolytes like sodium, potassium, and chloride were present in physiological concentrations in the effluent, while being at very low levels in the treated wastewater. From a physicochemical standpoint, the effluent’s pH was consistently stable and neutral, right around 7. In contrast, the treated wastewater showed a much wider pH range, often leaning towards acidity.

Now for the microbiological findings, which were perhaps the most dramatic. The peritoneal dialysis effluent was, for all intents and purposes, sterile. The researchers detected zero colony-forming units in any of the effluent samples. The treated wastewater, on the other hand, was teeming with microorganisms, despite having undergone treatment. Median counts in the wastewater samples were over 71,000 colony-forming units per 100 milliliters for aerobic bacteria and over 142,000 for total coliforms, indicating significant microbial loads and persistent fecal contamination.

In essence, the study found that peritoneal dialysis effluent is a biochemically concentrated but microbiologically clean fluid. Treated wastewater is the opposite: biochemically more dilute, but microbiologically contaminated.

This study provides a valuable, foundational dataset, but it's important to consider its context. A key strength is its novel, direct comparison between peritoneal effluent and treated wastewater, using the latter as a pragmatic benchmark for reuse standards. The laboratory methods were standardized and robust, providing reliable data on the specific parameters measured. This work establishes a critical baseline for any future discussions about recycling this fluid.

However, there are some limitations to keep in mind. The study was conducted at a single center with a small sample of only 20 patients, which may limit the generalizability of the findings. The composition of effluent could vary based on patient diet, medications, or residual renal function. Another limitation is the reliance on culture-based microbiology. While effective for common bacteria and fungi, this method doesn't detect non-cultivable organisms or viruses. More advanced molecular techniques could reveal a more complex microbial picture. The authors also note that their biochemical analysis was not exhaustive. They didn't screen for other potential contaminants like pharmaceuticals, hormones, or plastic-derived compounds, which would be crucial to assess before any environmental application. Finally, by design, the study excluded patients with peritonitis. The effluent from an infected patient would obviously be a biohazard and require entirely different handling, so these findings only apply to the fluid from uninfected patients.

So, what is the clinical bottom line from this research? For the practicing nephrologist, this paper doesn't change day-to-day patient care. Instead, it challenges us to think differently at a systems level about the byproducts of the therapies we prescribe. We should begin to see peritoneal dialysis effluent not just as waste, but as a potential water resource.

The key takeaway is that the primary barrier to reusing this fluid is not microbial, but chemical. The effluent from uninfected patients is sterile, which is a massive advantage. The problem is its high load of salts, glucose, and nitrogenous waste. This means that simply using it to water a garden is not advisable; the high osmolarity would likely damage soil and plants. However, the study strongly suggests that with appropriate advanced treatment—such as reverse osmosis, nanofiltration, or ultrafiltration—this effluent could be purified to a standard suitable for a variety of non-potable applications, like agricultural irrigation or industrial cleaning. This study serves as a proof-of-concept and a call to action. It highlights the need for engineers, public health experts, and policymakers to develop the technologies and regulatory frameworks necessary to make effluent reuse a safe and practical reality, moving nephrology toward a more sustainable and circular model of care.

That's your AudioScholar summary. The full transcript and reference are on the episode page. Until next time.

This is an automated summary generated by artificial intelligence, which can make mistakes. Always review the original source materials.